NSA Code Breaker Jim Simons' Hedge Fund Renaissance Technologies — Ozempic, Wegovy Maker Novo Nordisk Along With Nvidia, Palantir Among Top Holdings

Editor’s Note: The headline has been revised for clarity.

Renaissance Technologies, the hedge fund founded by legendary mathematician and former National Security Agency code breaker Jim Simons, recently disclosed its latest stock holdings in a 13F filing with the U.S. Securities and Exchange Commission on Aug. 9.

What Happened: The filing reveals significant changes in the fund’s portfolio, reflecting the quantitative strategies that have made Renaissance one of the most successful hedge funds in history.

Leading the pack is Novo Nordisk A/S (NYSE:NVO), a Danish pharmaceutical giant, which accounts for 2.22% of Renaissance’s portfolio with a market value of $1.3 billion. Despite a 15.03% reduction in shares, NVO remains the fund’s top holding.

In a notable shift, Palantir Technologies Inc. (NYSE:PLTR) ranks second, comprising 1.70% of the portfolio. However, Renaissance decreased its PLTR position by 16.56%, signaling a potential reassessment of the data analytics firm’s prospects.

NVIDIA Corp. (NASDAQ:NVDA), a leader in AI and graphics processing, saw a significant increase in Renaissance’s holdings. The fund boosted its NVDA shares by 27.52%, making it the third-largest position at 1.47% of the portfolio.

Other top holdings include Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) and United Therapeutics Corporation (NASDAQ:UTHR), underscoring Renaissance’s interest in the healthcare sector.

Notably, Broadcom Inc. (NASDAQ:AVGO) appears as a new position in the portfolio, claiming the ninth spot with 0.80% of total holdings and a market value of $472.21 million.

Tesla Inc. (NASDAQ:TSLA) completes the top 10, with Renaissance increasing its stake by 14.20%. TSLA now represents 0.69% of the portfolio, valued at $405.94 million.

See Also: More Than Half Of Fortune 500 Companies Flag AI As A Major Risk, Marking 473.5% Surge In Warnings Amid Growing Concerns

Read Next:

Image Via Shutterstock

Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editor

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.